Abstract
The management of childhood spasticity requires a multidisciplinary effort. With input from pediatricians, physical and occupational therapists, neurologists, orthotists, orthopedic surgeons, neurological surgeons, and other healthcare personnel, effective treatment for spasticity can be initiated and maintained that can lead to meaningful improvements in quality of life for vast numbers of children. Neurosurgical treatment of spasticity will continue to evolve and be refined as procedures and techniques are appropriately evaluated with reliable and validated outcome measures.
MeSH terms
-
Baclofen / administration & dosage*
-
Baclofen / therapeutic use
-
Cerebral Palsy* / classification
-
Cerebral Palsy* / diagnosis
-
Cerebral Palsy* / physiopathology
-
Humans
-
Infant
-
Injections, Spinal
-
Muscle Relaxants, Central / administration & dosage*
-
Muscle Relaxants, Central / therapeutic use
-
Muscle Spasticity* / etiology
-
Muscle Spasticity* / surgery
-
Muscle Spasticity* / therapy
-
Parasympatholytics / adverse effects
-
Parasympatholytics / therapeutic use*
-
Peripheral Nerves / surgery
-
Physical Examination
-
Randomized Controlled Trials as Topic
-
Rhizotomy
Substances
-
Muscle Relaxants, Central
-
Parasympatholytics
-
Baclofen